By doing so, cART reduces the amount of virus in the body to undetectable levels, thereby protecting and preserving these ...

In previous studies, the team's research with nonhuman primates showed that vaccines based on rhesus CMV, called RhCMV, trigger unique T cell responses not seen with any other vaccine. They found that ...

Women living with HIV can reduce their risk of cervical cancer using a human papillomavirus (HPV) vaccine that is both ...

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human ...

Using this model, the researchers proved that the virus can infect the cells directly and that the cells can't protect themselves against it through an immune response ... such as organ transplant ...

As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

ViiV Healthcare Announces Data Demonstrating Dovato (DTG/3TC) Is Highly Effective in Treatment-Naïve People With Advanced HIV ...

Are you planning to get a baby? Protect your child by screening for hereditary disorders that you may pass to them ...

Although still in early clinical trials, if successful, E-SYNC could one day become the first CAR-T therapy to treat the aggressive brain cancer glioblastoma. About 12,000 Americans are diagnosed with ...

Membrane-bound organelles were the textbook standard of how scientists thought cells were organized until they realized in the mid-2000s that some organelles don’t need to be wrapped in a membrane.

Other viruses that can directly cause cancer, like EBV and human T-cell lymphotropic virus ... increase the risk of cancer," Berzofsky said. HIV can also raise the risk of cancer developing ...